Latest Market News

Page 603 of 1876
AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.
Ada Torres
Ada Torres
20 Nov 2025
AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.
Victor Sage
Victor Sage
20 Nov 2025
AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.
Victor Sage
Victor Sage
20 Nov 2025
The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.
Victor Sage
Victor Sage
20 Nov 2025
Finbar Group Limited highlights strong sales momentum in 2025, underpinned by a $1.2 billion development pipeline and a buoyant Western Australian apartment market driven by migration and undersupply.
Eva Park
Eva Park
19 Nov 2025
Lloyds Banking Group is set to acquire London-based fintech Curve, aiming to enhance its mobile banking with advanced digital wallet features. The deal, expected to close in early 2026, marks a strategic push in Lloyds’ digital transformation journey.
Claire Turing
Claire Turing
19 Nov 2025
EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its women’s and men’s health products Dyspro™ and Libbo™.
Ada Torres
Ada Torres
19 Nov 2025
The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.
Victor Sage
Victor Sage
19 Nov 2025
The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.
Victor Sage
Victor Sage
19 Nov 2025
Mount Hope Mining has withdrawn its recently announced Share Purchase Plan, citing challenging market conditions. Shareholders will receive full refunds within days.
Maxwell Dee
Maxwell Dee
19 Nov 2025
Global X Management (AUS) Limited has announced estimated distribution amounts for three of its ETFs listed on the ASX AQUA Market for the period ending 30 November 2025, highlighting income opportunities for investors.
Claire Turing
Claire Turing
19 Nov 2025
I Synergy Group’s subsidiary has inked four separate 12-month leases for its AI computing hardware and software, marking a strategic push into recurring revenue streams.
Sophie Babbage
Sophie Babbage
19 Nov 2025